A carregar...

IL-21 in cancer immunotherapy: At the right place at the right time

Interleukin-21 (IL-21) has been described as a potent stimulator of antitumor T-cell immunity, but also of autoimmune reactions and oncogenesis. Antigen presenting cells genetically modified to release IL-21 allow for the expansion of tumor-specific T cells exhibiting favorable effector and growth c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Santegoets, Saskia JAM, Turksma, Annelies W., Powell Jr., Daniel J, Hooijberg, Erik, de Gruijl, Tanja D
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716748/
https://ncbi.nlm.nih.gov/pubmed/23894713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24522
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!